My Watchlist
Indicators
Silicon Valley 150
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Addex Therapeutics

< Previous 1 2 Next >
Addex Therapeutics to Report 2025 Half-year and Second Quarter Financial Results on September 30, 2025 and Host Conference Call on October 1, 2025
From Addex Therapeutics
Via GlobeNewswire
Addex Appoints Bank of New York Mellon as Depositary Bank
From Addex Therapeutics
Via GlobeNewswire
Addex Leads CHF 2 Million Investment in Stalicla to Advance Precision Medicine in Neuropsychiatric Disorders
From Addex Therapeutics
Via GlobeNewswire
Addex Shareholders Approve All Resolutions at Annual General Meeting
From Addex Therapeutics
Via GlobeNewswire
Addex Therapeutics Reports Q1 2025 Financial Results and Provides Corporate Update
From Addex Therapeutics
Via GlobeNewswire
Addex Therapeutics to Release Q1 2025 Financial Results and Host Conference Call on June 19, 2025
From Addex Therapeutics
Via GlobeNewswire
Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Multiple Chronic Cough Preclinical Models
From Addex Therapeutics
Via GlobeNewswire
Addex to Present Positive GABAB PAM Chronic Cough Data at the 10th American Cough Conference
From Addex Therapeutics
Via GlobeNewswire
Addex Convenes Annual General Meeting 2025
From Addex Therapeutics
Via GlobeNewswire
Addex Partner Indivior Advances GABAB Positive Allosteric Modulator Program Successfully Through IND Enabling Studies
From Addex Therapeutics
Via GlobeNewswire
Addex Enters Option Agreement with Sinntaxis for an Exclusive License to Intellectual Property Covering the Use of mGlu5 Inhibitors in Brain Injury Recovery
From Addex Therapeutics
Via GlobeNewswire
Addex Reports Full Year 2024 Financial Results and Provides Corporate Update
From Addex Therapeutics
Via GlobeNewswire
Addex Therapeutics to Release Full-Year 2024 Financial Results and Host Conference Call on April 25, 2025
From Addex Therapeutics
Via GlobeNewswire
Addex Regains Rights to Phase 2 mGlu2 PAM Asset ADX71149
From Addex Therapeutics
Via GlobeNewswire
Addex to Present at the 2025 Swiss Equities Baader Conference
From Addex Therapeutics
Via GlobeNewswire
Addex Reports Third Quarter 2024 Financial Results and Provides Corporate Update
From Addex Therapeutics
Via GlobeNewswire
Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024
From Addex Therapeutics
Via GlobeNewswire
Addex Therapeutics Reports 2024 Half Year and Second Quarter Financial Results and Provides Corporate Update
From Addex Therapeutics
Via GlobeNewswire
Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net Profit
From Addex Therapeutics
Via GlobeNewswire
Addex to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
From Addex Therapeutics
Via GlobeNewswire
Addex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research Collaboration
From Addex Therapeutics
Via GlobeNewswire
Addex’s Partner Discontinues ADX71149 development in Epilepsy
From Addex Therapeutics
Via GlobeNewswire
Addex Presents Positive Results from GABAB PAM Cough Program at the Thirteenth London International Cough Symposium (13th LICS)
From Addex Therapeutics
Via GlobeNewswire
Addex To Present at the Thirteenth London International Cough Symposium (13th LICS)
From Addex Therapeutics
Via GlobeNewswire
Addex Shareholders Approve All Resolutions at Annual General Meeting
From Addex Therapeutics
Via GlobeNewswire
Addex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate Update
From Addex Therapeutics
Via GlobeNewswire
Addex Convenes Annual General Meeting 2024
From Addex Therapeutics
Via GlobeNewswire
Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024
From Addex Therapeutics
Via GlobeNewswire
Addex to Present at Bio€quity Europe 2024
From Addex Therapeutics
Via GlobeNewswire
Addex Provides Update on ADX71149 Phase 2 Epilepsy Study
From Addex Therapeutics
Via GlobeNewswire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.